BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26672768)

  • 1. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.
    Lorenz S; Barøy T; Sun J; Nome T; Vodák D; Bryne JC; Håkelien AM; Fernandez-Cuesta L; Möhlendick B; Rieder H; Szuhai K; Zaikova O; Ahlquist TC; Thomassen GO; Skotheim RI; Lothe RA; Tarpey PS; Campbell P; Flanagan A; Myklebost O; Meza-Zepeda LA
    Oncotarget; 2016 Feb; 7(5):5273-88. PubMed ID: 26672768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array comparative genomic hybridization in osteosarcoma.
    Sadikovic B; Park PC; Selvarajah S; Zielenska M
    Methods Mol Biol; 2013; 973():227-47. PubMed ID: 23412794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
    Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
    Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.
    Difilippo V; Saba KH; Styring E; Magnusson L; Nilsson J; Nathrath M; Baumhoer D; Nord KH
    Lab Invest; 2024 Jan; 104(1):100283. PubMed ID: 37931683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma.
    Herold N
    Cancer Gene Ther; 2024 Feb; ():. PubMed ID: 38409586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clonal evolution of osteosarcomas].
    Baumhoer D
    Pathologe; 2016 Nov; 37(Suppl 2):163-168. PubMed ID: 27651058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.
    Saba KH; Difilippo V; Kovac M; Cornmark L; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Bidgoli M; Jonson T; Sumathi VP; Brosjö O; Staaf J; Foijer F; Styring E; Nathrath M; Baumhoer D; Nord KH
    J Pathol; 2024 Feb; 262(2):147-160. PubMed ID: 38010733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
    Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
    Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
    Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
    Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
    Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
    Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
    Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular characterization of plutonium-induced rat osteosarcomas.
    Roch-Lefevre S; Daino K; Altmeyer-Morel S; Guilly MN; Chevillard S
    J Radiat Res; 2010; 51(3):243-50. PubMed ID: 20505263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
    Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and the Immune Landscape of Osteosarcoma.
    Wu CC; Livingston JA
    Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and structure of p53 rearrangements in human osteosarcoma.
    Miller CW; Aslo A; Tsay C; Slamon D; Ishizaki K; Toguchida J; Yamamuro T; Lampkin B; Koeffler HP
    Cancer Res; 1990 Dec; 50(24):7950-4. PubMed ID: 2253237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
    Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
    Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas.
    Patiño-García A; Piñeiro ES; Díez MZ; Iturriagagoitia LG; Klüssmann FA; Ariznabarreta LS
    J Pediatr Hematol Oncol; 2003 May; 25(5):362-7. PubMed ID: 12759621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.